Literature DB >> 470336

[Unusually long survival times in patients with advanced Hodgkin's disease (author's transl)].

E Hiller, W Wilmanns, K Wilms.   

Abstract

Of 18 patients with advanced Hodgkin's disease who obtained a complete remission with a modified De Vita treatment protocol 15 maintained their complete remission for an average of 76 months till the end of the observation time.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 470336     DOI： 10.1007/bf01477557

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  10 in total

1.  [Long-term remission in advanced stages of lymphogranulomatosis following combined chemotherapy using a modified de Vita system].

Authors:  W Wilmanns; K Wilms; T Koos
Journal:  Hamatol Bluttransfus       Date:  1976

2.  Risk of new cancers in patients with Hodgkin's disease.

Authors:  J C Arseneau; G P Canellos; R Johnson; V T DeVita
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

3.  Hematologic neoplasia in patients treated for Hodgkin's disease.

Authors:  C N Coleman; C J Williams; A Flint; E J Glatstein; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1977-12-08       Impact factor: 91.245

Review 4.  A decade of combination chemotherapy of advanced Hodgkin's disease.

Authors:  V T DeVita; G P Canellos; J H Moxley
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

5.  Survival and relapse rates in Hodgkin's disease: Stanford experience, 1961-71.

Authors:  H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

6.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

7.  [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

Authors:  F J Tigges; E Hiller; R M Schmülling; H D Waller; K Wilms
Journal:  Blut       Date:  1978-08-15

8.  Improved survival in hodgkin's disease.

Authors:  A C Aisenberg; R Qazi
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

9.  [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].

Authors:  F J Tigges; R M Schmülling; E Hiller; H D Waller; K Wilms
Journal:  Dtsch Med Wochenschr       Date:  1977-10-28       Impact factor: 0.628

10.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.